BindingDB logo
myBDB logout

Patent code US9796742

Compile Data Set for Download or QSAR
Found 135 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354311
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354293
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354310
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354332
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354293
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354324
PNG
(1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...)
Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354311
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354310
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354324
PNG
(1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...)
Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354309
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354304
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354304
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354331
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354329
PNG
(1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354330
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354273
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354332
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354323
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C44H50N7O6P/c1-30(2)40-28-43(51(49-40)33-10-8-9-31(23-33)29-58(4,5)53)48-44(52)47-39-13-14-41(38-12-7-6-11-37(38)39)57-34-15-16-45-42(27-34)46-32-24-35(54-3)26-36(25-32)56-22-19-50-17-20-55-21-18-50/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,45,46)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354308
PNG
(1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...)
Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354308
PNG
(1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...)
Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354329
PNG
(1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354294
PNG
(1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...)
Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354310
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354309
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354276
PNG
(1-(1-(4-(Dimethylphosphoryl)phenyl)-3-isopropyl-1H...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C35H34N7O3P/c1-23(2)30-22-32(42(41-30)25-14-16-26(17-15-25)46(3,4)44)39-35(43)38-29-18-19-31(28-13-9-8-12-27(28)29)45-33-20-21-36-34(40-33)37-24-10-6-5-7-11-24/h5-23H,1-4H3,(H,36,37,40)(H2,38,39,43)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354330
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354311
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354333
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354273
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354275
PNG
(N-(4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylphosphor...)
Show SMILES COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)ccn1
Show InChI InChI=1S/C34H37N6O5P/c1-34(2,3)29-20-31(40(39-29)22-11-13-24(14-12-22)46(5,6)43)38-33(42)36-27-15-16-28(26-10-8-7-9-25(26)27)45-23-17-18-35-30(19-23)37-32(41)21-44-4/h7-20H,21H2,1-6H3,(H,35,37,41)(H2,36,38,42)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 16n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354331
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354324
PNG
(1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...)
Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354317
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N7O8P/c1-30(2)39-28-41(51(50-39)33-11-9-10-31(24-33)29-60(5,6)53)48-44(52)47-38-14-15-40(37-13-8-7-12-36(37)38)59-42-16-17-45-43(49-42)46-32-25-34(55-4)27-35(26-32)58-23-22-57-21-20-56-19-18-54-3/h7-17,24-28,30H,18-23,29H2,1-6H3,(H,45,46,49)(H2,47,48,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354329
PNG
(1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354322
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C45H51N8O6P/c1-30(2)40-28-43(53(51-40)34-10-8-9-31(23-34)29-60(4,5)56)50-45(55)49-39-13-14-41(38-12-7-6-11-37(38)39)59-35-15-16-46-42(27-35)48-33-24-32(25-36(26-33)57-3)44(54)47-17-18-52-19-21-58-22-20-52/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,46,48)(H,47,54)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354333
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354302
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(CCCO)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C34H40N7O4P/c1-34(2,3)29-22-30(41(39-29)23-12-14-24(15-13-23)46(5,6)44)37-33(43)36-27-16-17-28(26-11-8-7-10-25(26)27)45-31-18-19-35-32(38-31)40(4)20-9-21-42/h7-8,10-19,22,42H,9,20-21H2,1-6H3,(H2,36,37,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 27n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354273
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354295
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-15-11-12-25(22-27)24-48(4,5)46)41-36(45)40-30-18-19-31(29-17-10-9-16-28(29)30)47-34-20-21-38-35(42-34)39-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 40n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354293
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 44n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354314
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H37N6O3P/c1-25(2)33-23-36(43(42-33)28-14-10-11-26(21-28)24-47(3,4)45)41-37(44)40-32-17-18-34(31-16-9-8-15-30(31)32)46-29-19-20-38-35(22-29)39-27-12-6-5-7-13-27/h5-23,25H,24H2,1-4H3,(H,38,39)(H2,40,41,44)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 47n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354287
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(c1ccccc1)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-24-33(44(42-32)26-16-18-27(19-17-26)48(5,6)46)40-36(45)39-30-20-21-31(29-15-11-10-14-28(29)30)47-34-22-23-38-35(41-34)43(4)25-12-8-7-9-13-25/h7-24H,1-6H3,(H2,39,40,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 56n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354313
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H39N6O3P/c1-38(2,3)34-24-36(44(43-34)28-15-11-12-26(22-28)25-48(4,5)46)42-37(45)41-32-18-19-33(31-17-10-9-16-30(31)32)47-29-20-21-39-35(23-29)40-27-13-7-6-8-14-27/h6-24H,25H2,1-5H3,(H,39,40)(H2,41,42,45)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 56n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354323
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C44H50N7O6P/c1-30(2)40-28-43(51(49-40)33-10-8-9-31(23-33)29-58(4,5)53)48-44(52)47-39-13-14-41(38-12-7-6-11-37(38)39)57-34-15-16-45-42(27-34)46-32-24-35(54-3)26-36(25-32)56-22-19-50-17-20-55-21-18-50/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,45,46)(H2,47,48,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 58n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354304
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 60n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354314
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H37N6O3P/c1-25(2)33-23-36(43(42-33)28-14-10-11-26(21-28)24-47(3,4)45)41-37(44)40-32-17-18-34(31-16-9-8-15-30(31)32)46-29-19-20-38-35(22-29)39-27-12-6-5-7-13-27/h5-23,25H,24H2,1-4H3,(H,38,39)(H2,40,41,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 63n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354294
PNG
(1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...)
Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 67n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354292
PNG
(1-(4-((2-((3-Aminobenzo[d]isoxazol-5-yl)amino)pyri...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C37H36N9O4P/c1-37(2,3)31-21-32(46(44-31)23-11-13-24(14-12-23)51(4,5)48)42-36(47)41-28-15-17-29(26-9-7-6-8-25(26)28)49-33-18-19-39-35(43-33)40-22-10-16-30-27(20-22)34(38)45-50-30/h6-21H,1-5H3,(H2,38,45)(H,39,40,43)(H2,41,42,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 68n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354309
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 70n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354332
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 71n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354288
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-(dimethylphospho...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(c1)P(C)(C)=O
Show InChI InChI=1S/C43H48N9O5P/c1-43(2,3)37-28-38(52(50-37)31-12-9-13-32(27-31)58(4,5)55)48-42(54)47-35-16-17-36(34-15-7-6-14-33(34)35)57-39-18-19-45-41(49-39)46-30-11-8-10-29(26-30)40(53)44-20-21-51-22-24-56-25-23-51/h6-19,26-28H,20-25H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 72n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354284
PNG
(1-(4-((2-((3-Aminobenzo[d]isoxazol-5-yl)amino)pyri...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)n(n1)-c1cccc(c1)P(C)(C)=O
Show InChI InChI=1S/C37H36N9O4P/c1-37(2,3)31-21-32(46(44-31)23-9-8-10-24(20-23)51(4,5)48)42-36(47)41-28-14-16-29(26-12-7-6-11-25(26)28)49-33-17-18-39-35(43-33)40-22-13-15-30-27(19-22)34(38)45-50-30/h6-21H,1-5H3,(H2,38,45)(H,39,40,43)(H2,41,42,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 73n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354289
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc(OCCN5CCOCC5)c4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C42H47N8O5P/c1-42(2,3)37-28-38(50(48-37)30-13-15-32(16-14-30)56(4,5)52)46-41(51)45-35-17-18-36(34-12-7-6-11-33(34)35)55-39-19-20-43-40(47-39)44-29-9-8-10-31(27-29)54-26-23-49-21-24-53-25-22-49/h6-20,27-28H,21-26H2,1-5H3,(H,43,44,47)(H2,45,46,51)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 74n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354291
PNG
((4-(3-(tert-Butyl)-5-(3-(4-((2-(phenylamino)pyrimi...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(O)=O
Show InChI InChI=1S/C35H34N7O4P/c1-35(2,3)30-22-31(42(41-30)24-14-16-25(17-15-24)47(4,44)45)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)46-32-20-21-36-33(40-32)37-23-10-6-5-7-11-23/h5-22H,1-4H3,(H,44,45)(H,36,37,40)(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 76n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354331
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 81n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354330
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 84n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354320
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(OC(F)(F)F)c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O6P/c1-28(2)37-26-39(54(52-37)31-9-7-8-29(22-31)27-61(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-30-23-32(25-33(24-30)60-43(44,45)46)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 87n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354321
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O5P/c1-28(2)37-26-39(54(52-37)32-9-7-8-29(22-32)27-60(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-31-23-30(43(44,45)46)24-33(25-31)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 95n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354313
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H39N6O3P/c1-38(2,3)34-24-36(44(43-34)28-15-11-12-26(22-28)25-48(4,5)46)42-37(45)41-32-18-19-33(31-17-10-9-16-30(31)32)47-29-20-21-39-35(23-29)40-27-13-7-6-8-14-27/h6-24H,25H2,1-5H3,(H,39,40)(H2,41,42,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 96n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354295
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-15-11-12-25(22-27)24-48(4,5)46)41-36(45)40-30-18-19-31(29-17-10-9-16-28(29)30)47-34-20-21-38-35(42-34)39-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 97n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354301
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Sc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35N6O3PS/c1-36(2,3)31-23-32(42(41-31)24-15-17-25(18-16-24)46(4,5)44)39-34(43)38-29-19-20-30(28-14-10-9-13-27(28)29)45-33-21-22-37-35(40-33)47-26-11-7-6-8-12-26/h6-23H,1-5H3,(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 149n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354308
PNG
(1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...)
Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 159n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354297
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(cc4)P(C)(C)=O)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C38H41N7O4P2/c1-38(2,3)33-24-34(45(44-33)26-14-18-28(19-15-26)51(6,7)48)42-37(46)41-31-20-21-32(30-11-9-8-10-29(30)31)49-35-22-23-39-36(43-35)40-25-12-16-27(17-13-25)50(4,5)47/h8-24H,1-7H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 163n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354290
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(SCCO)cc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C38H40N7O4PS/c1-38(2,3)33-24-34(45(44-33)26-12-14-27(15-13-26)50(4,5)48)42-37(47)41-31-18-19-32(30-9-7-6-8-29(30)31)49-35-20-21-39-36(43-35)40-25-10-16-28(17-11-25)51-23-22-46/h6-21,24,46H,22-23H2,1-5H3,(H,39,40,43)(H2,41,42,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 168n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354315
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(=O)NCCN4CCOCC4)C#C)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H48N9O5P/c1-6-31-24-33(43(55)46-18-19-53-20-22-58-23-21-53)27-34(25-31)48-44-47-17-16-42(51-44)59-40-15-14-38(36-12-7-8-13-37(36)40)49-45(56)50-41-28-39(30(2)3)52-54(41)35-11-9-10-32(26-35)29-60(4,5)57/h1,7-17,24-28,30H,18-23,29H2,2-5H3,(H,46,55)(H,47,48,51)(H2,49,50,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 174n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354278
PNG
(1-(3-(tert-Butyl)-1-(4-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(CP(C)(C)=O)cc1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-17-15-25(16-18-27)24-48(4,5)46)41-36(45)40-30-19-20-31(29-14-10-9-13-28(29)30)47-34-21-22-38-35(42-34)39-26-11-7-6-8-12-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 183n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354325
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)S(C)(=O)=O)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H49N8O7PS/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-59(3,4)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)58-41-15-16-44-42(48-41)45-31-24-33(26-34(25-31)60(5,54)55)57-22-19-50-17-20-56-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 188n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354294
PNG
(1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...)
Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 200n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354316
PNG
(1-(3-(tert-Butyl)-1-(3-((1-oxidophospholan-1-yl)me...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP2(=O)CCCC2)c1
Show InChI InChI=1S/C40H41N6O3P/c1-40(2,3)36-26-38(46(45-36)30-15-11-12-28(24-30)27-50(48)22-9-10-23-50)44-39(47)43-34-18-19-35(33-17-8-7-16-32(33)34)49-31-20-21-41-37(25-31)42-29-13-5-4-6-14-29/h4-8,11-21,24-26H,9-10,22-23,27H2,1-3H3,(H,41,42)(H2,43,44,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 201n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354321
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O5P/c1-28(2)37-26-39(54(52-37)32-9-7-8-29(22-32)27-60(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-31-23-30(43(44,45)46)24-33(25-31)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 202n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354283
PNG
(1-(3-(tert-Butyl)-1-(3-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CC(=O)Nc5c4)n3)c3ccccc23)n(n1)-c1cccc(c1)P(C)(C)=O
Show InChI InChI=1S/C38H37N8O4P/c1-38(2,3)32-22-33(46(45-32)25-9-8-10-26(21-25)51(4,5)49)43-37(48)42-29-15-16-31(28-12-7-6-11-27(28)29)50-35-17-18-39-36(44-35)40-24-14-13-23-19-34(47)41-30(23)20-24/h6-18,20-22H,19H2,1-5H3,(H,41,47)(H,39,40,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 205n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354285
PNG
(1-(3-(tert-Butyl)-1-(3-(dimethylphosphoryl)phenyl)...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(c4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C38H38N9O3P/c1-23-18-25(19-24-22-40-45-35(23)24)41-36-39-17-16-34(44-36)50-31-15-14-30(28-12-7-8-13-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-10-9-11-27(20-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 208n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354303
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(NCCCO)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C33H38N7O4P/c1-33(2,3)28-21-29(40(39-28)22-11-13-23(14-12-22)45(4,5)43)37-32(42)36-26-15-16-27(25-10-7-6-9-24(25)26)44-30-17-19-35-31(38-30)34-18-8-20-41/h6-7,9-17,19,21,41H,8,18,20H2,1-5H3,(H,34,35,38)(H2,36,37,42)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 211n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354321
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O5P/c1-28(2)37-26-39(54(52-37)32-9-7-8-29(22-32)27-60(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-31-23-30(43(44,45)46)24-33(25-31)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 219n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354276
PNG
(1-(1-(4-(Dimethylphosphoryl)phenyl)-3-isopropyl-1H...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C35H34N7O3P/c1-23(2)30-22-32(42(41-30)25-14-16-26(17-15-25)46(3,4)44)39-35(43)38-29-18-19-31(28-13-9-8-12-27(28)29)45-33-20-21-36-34(40-33)37-24-10-6-5-7-11-24/h5-23H,1-4H3,(H,36,37,40)(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 220n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354320
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(OC(F)(F)F)c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O6P/c1-28(2)37-26-39(54(52-37)31-9-7-8-29(22-31)27-61(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-30-23-32(25-33(24-30)60-43(44,45)46)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 231n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354320
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(OC(F)(F)F)c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O6P/c1-28(2)37-26-39(54(52-37)31-9-7-8-29(22-31)27-61(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-30-23-32(25-33(24-30)60-43(44,45)46)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 232n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354295
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-15-11-12-25(22-27)24-48(4,5)46)41-36(45)40-30-18-19-31(29-17-10-9-16-28(29)30)47-34-20-21-38-35(42-34)39-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 265n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354296
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylphospho...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C43H48N9O5P/c1-43(2,3)37-28-38(52(50-37)31-13-15-32(16-14-31)58(4,5)55)48-42(54)47-35-17-18-36(34-12-7-6-11-33(34)35)57-39-19-20-45-41(49-39)46-30-10-8-9-29(27-30)40(53)44-21-22-51-23-25-56-26-24-51/h6-20,27-28H,21-26H2,1-5H3,(H,44,53)(H,45,46,49)(H2,47,48,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 293n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354286
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CC(=O)Nc5c4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C38H37N8O4P/c1-38(2,3)32-22-33(46(45-32)25-12-14-26(15-13-25)51(4,5)49)43-37(48)42-29-16-17-31(28-9-7-6-8-27(28)29)50-35-18-19-39-36(44-35)40-24-11-10-23-20-34(47)41-30(23)21-24/h6-19,21-22H,20H2,1-5H3,(H,41,47)(H,39,40,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 294n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354333
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 303n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354306
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc(OCCN5CCOCC5)c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H49N8O5P/c1-43(2,3)38-28-39(51(49-38)32-12-8-10-30(26-32)29-57(4,5)53)47-42(52)46-36-16-17-37(35-15-7-6-14-34(35)36)56-40-18-19-44-41(48-40)45-31-11-9-13-33(27-31)55-25-22-50-20-23-54-24-21-50/h6-19,26-28H,20-25,29H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 324n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354305
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5CC(=O)Nc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C39H39N8O4P/c1-39(2,3)33-22-34(47(46-33)27-10-8-9-24(19-27)23-52(4,5)50)44-38(49)43-30-15-16-32(29-12-7-6-11-28(29)30)51-36-17-18-40-37(45-36)41-26-14-13-25-20-35(48)42-31(25)21-26/h6-19,21-22H,20,23H2,1-5H3,(H,42,48)(H,40,41,45)(H2,43,44,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 326n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354313
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H39N6O3P/c1-38(2,3)34-24-36(44(43-34)28-15-11-12-26(22-28)25-48(4,5)46)42-37(45)41-32-18-19-33(31-17-10-9-16-30(31)32)47-29-20-21-39-35(23-29)40-27-13-7-6-8-14-27/h6-24H,25H2,1-5H3,(H,39,40)(H2,41,42,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 357n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354300
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(cc4)S(F)(F)(F)(F)F)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35F5N7O3PS/c1-36(2,3)31-22-32(48(47-31)24-12-14-25(15-13-24)52(4,5)50)45-35(49)44-29-18-19-30(28-9-7-6-8-27(28)29)51-33-20-21-42-34(46-33)43-23-10-16-26(17-11-23)53(37,38,39,40)41/h6-22H,1-5H3,(H,42,43,46)(H2,44,45,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 372n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354319
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C45H52N9O6P/c1-45(2,3)39-28-40(54(52-39)33-11-9-10-30(24-33)29-61(5,6)57)50-44(56)49-37-14-15-38(36-13-8-7-12-35(36)37)60-41-16-17-47-43(51-41)48-32-25-31(26-34(27-32)58-4)42(55)46-18-19-53-20-22-59-23-21-53/h7-17,24-28H,18-23,29H2,1-6H3,(H,46,55)(H,47,48,51)(H2,49,50,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 406n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354277
PNG
(1-(1-(4-(Dimethylphosphoryl)phenyl)-3-(trimethylsi...)
Show SMILES C[Si](C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C35H36N7O3PSi/c1-46(2,44)26-17-15-25(16-18-26)42-31(23-33(41-42)47(3,4)5)39-35(43)38-29-19-20-30(28-14-10-9-13-27(28)29)45-32-21-22-36-34(40-32)37-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,36,37,40)(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 429n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354279
PNG
(1-(4-((2-((1H-Indazol-5-yl)amino)pyrimidin-4-yl)ox...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C37H36N9O3P/c1-37(2,3)32-21-33(46(45-32)25-11-13-26(14-12-25)50(4,5)48)42-36(47)41-30-16-17-31(28-9-7-6-8-27(28)30)49-34-18-19-38-35(43-34)40-24-10-15-29-23(20-24)22-39-44-29/h6-22H,1-5H3,(H,39,44)(H,38,40,43)(H2,41,42,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 486n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354274
PNG
(1-(3-(tert-Butyl)-1-(3-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(c1)P(C)(C)=O
Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-14-11-15-26(22-25)47(4,5)45)40-35(44)39-29-18-19-30(28-17-10-9-16-27(28)29)46-33-20-21-37-34(41-33)38-24-12-7-6-8-13-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 647n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354282
PNG
(1-(4-((2-((1H-Indazol-5-yl)amino)pyrimidin-4-yl)ox...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(c1)P(C)(C)=O
Show InChI InChI=1S/C37H36N9O3P/c1-37(2,3)32-21-33(46(45-32)25-9-8-10-26(20-25)50(4,5)48)42-36(47)41-30-15-16-31(28-12-7-6-11-27(28)30)49-34-17-18-38-35(43-34)40-24-13-14-29-23(19-24)22-39-44-29/h6-22H,1-5H3,(H,39,44)(H,38,40,43)(H2,41,42,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 684n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354330
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(F)(F)F)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O5P/c1-44(2,3)38-27-39(57(55-38)33-10-8-9-29(23-33)28-63(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-32-25-30(24-31(26-32)45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 689n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354293
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)P(C)(C)=O)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C38H38N9O3P/c1-23-19-25(20-24-22-40-45-35(23)24)41-36-39-18-17-34(44-36)50-31-16-15-30(28-9-7-8-10-29(28)31)42-37(48)43-33-21-32(38(2,3)4)46-47(33)26-11-13-27(14-12-26)51(5,6)49/h7-22H,1-6H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 761n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354328
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#C)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C44H47N8O5P/c1-6-31-24-33(27-35(26-31)56-23-20-51-18-21-55-22-19-51)46-43-45-17-16-42(49-43)57-40-15-14-38(36-12-7-8-13-37(36)40)47-44(53)48-41-28-39(30(2)3)50-52(41)34-11-9-10-32(25-34)29-58(4,5)54/h1,7-17,24-28,30H,18-23,29H2,2-5H3,(H,45,46,49)(H2,47,48,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 788n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354302
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(CCCO)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C34H40N7O4P/c1-34(2,3)29-22-30(41(39-29)23-12-14-24(15-13-23)46(5,6)44)37-33(43)36-27-16-17-28(26-11-8-7-10-25(26)27)45-31-18-19-35-32(38-31)40(4)20-9-21-42/h7-8,10-19,22,42H,9,20-21H2,1-6H3,(H2,36,37,43)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 795n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354294
PNG
(1-(3-(tert-Butyl)-1-(4-(diethylphosphoryl)phenyl)-...)
Show SMILES CCP(=O)(CC)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C38H40N7O3P/c1-6-49(47,7-2)28-19-17-27(18-20-28)45-34(25-33(44-45)38(3,4)5)42-37(46)41-31-21-22-32(30-16-12-11-15-29(30)31)48-35-23-24-39-36(43-35)40-26-13-9-8-10-14-26/h8-25H,6-7H2,1-5H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 818n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354280
PNG
(1-(3-(tert-Butyl)-1-(4-(1-oxidophospholan-1-yl)phe...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P1(=O)CCCC1
Show InChI InChI=1S/C38H38N7O3P/c1-38(2,3)33-25-34(45(44-33)27-15-17-28(18-16-27)49(47)23-9-10-24-49)42-37(46)41-31-19-20-32(30-14-8-7-13-29(30)31)48-35-21-22-39-36(43-35)40-26-11-5-4-6-12-26/h4-8,11-22,25H,9-10,23-24H2,1-3H3,(H,39,40,43)(H2,41,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 849n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354300
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(cc4)S(F)(F)(F)(F)F)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35F5N7O3PS/c1-36(2,3)31-22-32(48(47-31)24-12-14-25(15-13-24)52(4,5)50)45-35(49)44-29-18-19-30(28-9-7-6-8-27(28)29)51-33-20-21-42-34(46-33)43-23-10-16-26(17-11-23)53(37,38,39,40)41/h6-22H,1-5H3,(H,42,43,46)(H2,44,45,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 884n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354299
PNG
((R)-1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phe...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(n3)N3CCC[C@@H]3CO)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C35H40N7O4P/c1-35(2,3)30-21-31(42(40-30)23-12-14-25(15-13-23)47(4,5)45)38-34(44)37-28-16-17-29(27-11-7-6-10-26(27)28)46-32-18-19-36-33(39-32)41-20-8-9-24(41)22-43/h6-7,10-19,21,24,43H,8-9,20,22H2,1-5H3,(H2,37,38,44)/t24-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 979n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354287
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(c1ccccc1)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-24-33(44(42-32)26-16-18-27(19-17-26)48(5,6)46)40-36(45)39-30-20-21-31(29-15-11-10-14-28(29)30)47-34-22-23-38-35(41-34)43(4)25-12-8-7-9-13-25/h7-24H,1-6H3,(H2,39,40,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.00E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM354300
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(cc4)S(F)(F)(F)(F)F)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35F5N7O3PS/c1-36(2,3)31-22-32(48(47-31)24-12-14-25(15-13-24)52(4,5)50)45-35(49)44-29-18-19-30(28-9-7-6-8-27(28)29)51-33-20-21-42-34(46-33)43-23-10-16-26(17-11-23)53(37,38,39,40)41/h6-22H,1-5H3,(H,42,43,46)(H2,44,45,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.00E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the leve...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354332
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H54N7O8P/c1-45(2,3)40-29-41(52(51-40)33-12-10-11-31(25-33)30-61(6,7)54)49-44(53)48-38-15-16-39(37-14-9-8-13-36(37)38)60-42-17-18-46-43(50-42)47-32-26-34(56-5)28-35(27-32)59-24-23-58-22-21-57-20-19-55-4/h8-18,25-29H,19-24,30H2,1-7H3,(H,46,47,50)(H2,48,49,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.10E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354317
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N7O8P/c1-30(2)39-28-41(51(50-39)33-11-9-10-31(24-33)29-60(5,6)53)48-44(52)47-38-14-15-40(37-13-8-7-12-36(37)38)59-42-16-17-45-43(49-42)46-32-25-34(55-4)27-35(26-32)58-23-22-57-21-20-56-19-18-54-3/h7-17,24-28,30H,18-23,29H2,1-6H3,(H,45,46,49)(H2,47,48,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.13E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354324
PNG
(1-(4-((2-((3-(2,5,8,11-Tetraoxatridecan-13-yloxy)-...)
Show SMILES COCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C46H56N7O9P/c1-32(2)41-30-43(53(52-41)35-11-9-10-33(26-35)31-63(5,6)55)50-46(54)49-40-14-15-42(39-13-8-7-12-38(39)40)62-44-16-17-47-45(51-44)48-34-27-36(57-4)29-37(28-34)61-25-24-60-23-22-59-21-20-58-19-18-56-3/h7-17,26-30,32H,18-25,31H2,1-6H3,(H,47,48,51)(H2,49,50,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.19E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354331
PNG
(3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosph...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC(F)(F)F)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C45H49F3N9O6P/c1-44(2,3)38-27-39(57(55-38)32-10-8-9-29(23-32)28-64(4,5)60)53-43(59)52-36-13-14-37(35-12-7-6-11-34(35)36)62-40-15-16-50-42(54-40)51-31-24-30(25-33(26-31)63-45(46,47)48)41(58)49-17-18-56-19-21-61-22-20-56/h6-16,23-27H,17-22,28H2,1-5H3,(H,49,58)(H,50,51,54)(H2,52,53,59)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.24E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354329
PNG
(1-(4-((2-((3-cyano-5-(2-morpholinoethoxy)phenyl)am...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C#N)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46N9O5P/c1-29(2)38-26-40(52(50-38)33-9-7-8-30(23-33)28-58(3,4)54)48-43(53)47-37-12-13-39(36-11-6-5-10-35(36)37)57-41-14-15-45-42(49-41)46-32-22-31(27-44)24-34(25-32)56-21-18-51-16-19-55-20-17-51/h5-15,22-26,29H,16-21,28H2,1-4H3,(H,45,46,49)(H2,47,48,53)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.25E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354310
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C44H50N9O6P/c1-29(2)38-27-40(53(51-38)33-10-8-9-30(23-33)28-60(4,5)56)49-44(55)48-37-13-14-39(36-12-7-6-11-35(36)37)59-41-15-16-46-43(50-41)47-32-24-31(25-34(26-32)57-3)42(54)45-17-18-52-19-21-58-22-20-52/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,45,54)(H,46,47,50)(H2,48,49,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.25E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354307
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-(tri...)
Show SMILES C[Si](C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C36H38N7O3PSi/c1-47(2,45)24-25-12-11-15-27(22-25)43-32(23-34(42-43)48(3,4)5)40-36(44)39-30-18-19-31(29-17-10-9-16-28(29)30)46-33-20-21-37-35(41-33)38-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.27E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354273
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H36N7O3P/c1-36(2,3)31-23-32(43(42-31)25-15-17-26(18-16-25)47(4,5)45)40-35(44)39-29-19-20-30(28-14-10-9-13-27(28)29)46-33-21-22-37-34(41-33)38-24-11-7-6-8-12-24/h6-23H,1-5H3,(H,37,38,41)(H2,39,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.28E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354304
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc2cn[nH]c12
Show InChI InChI=1S/C39H40N9O3P/c1-24-18-27(20-26-22-41-46-36(24)26)42-37-40-17-16-35(45-37)51-32-15-14-31(29-12-7-8-13-30(29)32)43-38(49)44-34-21-33(39(2,3)4)47-48(34)28-11-9-10-25(19-28)23-52(5,6)50/h7-22H,23H2,1-6H3,(H,41,46)(H,40,42,45)(H2,43,44,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.32E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354281
PNG
(Ethyl (4-(3-(tert-butyl)-5-(3-(4-((2-(phenylamino)...)
Show SMILES CCOP(C)(=O)c1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3ccccc3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C37H38N7O4P/c1-6-47-49(5,46)27-18-16-26(17-19-27)44-33(24-32(43-44)37(2,3)4)41-36(45)40-30-20-21-31(29-15-11-10-14-28(29)30)48-34-22-23-38-35(42-34)39-25-12-8-7-9-13-25/h7-24H,6H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.45E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354318
PNG
(1-(4-((2-((3-(Cyclopropylsulfonyl)-5-methoxyphenyl...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(c1)S(=O)(=O)C1CC1
Show InChI InChI=1S/C40H42N7O6PS/c1-25(2)35-23-37(47(46-35)28-10-8-9-26(19-28)24-54(4,5)49)44-40(48)43-34-15-16-36(33-12-7-6-11-32(33)34)53-38-17-18-41-39(45-38)42-27-20-29(52-3)22-31(21-27)55(50,51)30-13-14-30/h6-12,15-23,25,30H,13-14,24H2,1-5H3,(H,41,42,45)(H2,43,44,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.60E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354295
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-23-33(44(43-32)27-15-11-12-25(22-27)24-48(4,5)46)41-36(45)40-30-18-19-31(29-17-10-9-16-28(29)30)47-34-20-21-38-35(42-34)39-26-13-7-6-8-14-26/h6-23H,24H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.64E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354327
PNG
(1-(4-((2-((3-(2,5,8,11,14-Pentaoxahexadecan-16-ylo...)
Show SMILES COCCOCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C48H60N7O10P/c1-34(2)43-32-45(55(54-43)37-11-9-10-35(28-37)33-66(5,6)57)52-48(56)51-42-14-15-44(41-13-8-7-12-40(41)42)65-46-16-17-49-47(53-46)50-36-29-38(59-4)31-39(30-36)64-27-26-63-25-24-62-23-22-61-21-20-60-19-18-58-3/h7-17,28-32,34H,18-27,33H2,1-6H3,(H,49,50,53)(H2,51,52,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.67E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354322
PNG
(3-((4-((4-(3-(1-(3-((Dimethylphosphoryl)methyl)phe...)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C45H51N8O6P/c1-30(2)40-28-43(53(51-40)34-10-8-9-31(23-34)29-60(4,5)56)50-45(55)49-39-13-14-41(38-12-7-6-11-37(38)39)59-35-15-16-46-42(27-35)48-33-24-32(25-36(26-33)57-3)44(54)47-17-18-52-19-21-58-22-20-52/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,46,48)(H,47,54)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.09E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354311
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)n2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C43H49N8O6P/c1-29(2)38-27-40(51(49-38)32-10-8-9-30(23-32)28-58(4,5)53)47-43(52)46-37-13-14-39(36-12-7-6-11-35(36)37)57-41-15-16-44-42(48-41)45-31-24-33(54-3)26-34(25-31)56-22-19-50-17-20-55-21-18-50/h6-16,23-27,29H,17-22,28H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.23E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354323
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ccccc34)ccn2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C44H50N7O6P/c1-30(2)40-28-43(51(49-40)33-10-8-9-31(23-33)29-58(4,5)53)48-44(52)47-39-13-14-41(38-12-7-6-11-37(38)39)57-34-15-16-45-42(27-34)46-32-24-35(54-3)26-36(25-32)56-22-19-50-17-20-55-21-18-50/h6-16,23-28,30H,17-22,29H2,1-5H3,(H,45,46)(H2,47,48,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2.81E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354308
PNG
(1-(3-(tert-Butyl)-1-(3-((diethylphosphoryl)methyl)...)
Show SMILES CCP(=O)(CC)Cc1cccc(c1)-n1nc(cc1NC(=O)Nc1ccc(Oc2ccnc(Nc3cc(C)c4[nH]ncc4c3)n2)c2ccccc12)C(C)(C)C
Show InChI InChI=1S/C41H44N9O3P/c1-7-54(52,8-2)25-27-12-11-13-30(21-27)50-36(23-35(49-50)41(4,5)6)46-40(51)45-33-16-17-34(32-15-10-9-14-31(32)33)53-37-18-19-42-39(47-37)44-29-20-26(3)38-28(22-29)24-43-48-38/h9-24H,7-8,25H2,1-6H3,(H,43,48)(H,42,44,47)(H2,45,46,51)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.41E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354333
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C44H48F3N8O5P/c1-43(2,3)38-27-39(55(53-38)32-10-8-9-29(23-32)28-61(4,5)57)51-42(56)50-36-13-14-37(35-12-7-6-11-34(35)36)60-40-15-16-48-41(52-40)49-31-24-30(44(45,46)47)25-33(26-31)59-22-19-54-17-20-58-21-18-54/h6-16,23-27H,17-22,28H2,1-5H3,(H,48,49,52)(H2,50,51,56)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.19E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354313
PNG
(1-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H39N6O3P/c1-38(2,3)34-24-36(44(43-34)28-15-11-12-26(22-28)25-48(4,5)46)42-37(45)41-32-18-19-33(31-17-10-9-16-30(31)32)47-29-20-21-39-35(23-29)40-27-13-7-6-8-14-27/h6-24H,25H2,1-5H3,(H,39,40)(H2,41,42,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.33E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354309
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C38H38N9O3P/c1-23(2)32-20-34(47(46-32)28-10-8-9-25(18-28)22-51(4,5)49)43-38(48)42-31-13-14-33(30-12-7-6-11-29(30)31)50-35-15-16-39-37(44-35)41-27-17-24(3)36-26(19-27)21-40-45-36/h6-21,23H,22H2,1-5H3,(H,40,45)(H,39,41,44)(H2,42,43,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.86E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354314
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C37H37N6O3P/c1-25(2)33-23-36(43(42-33)28-14-10-11-26(21-28)24-47(3,4)45)41-37(44)40-32-17-18-34(31-16-9-8-15-30(31)32)46-29-19-20-38-35(22-29)39-27-12-6-5-7-13-27/h5-23,25H,24H2,1-4H3,(H,38,39)(H2,40,41,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6.98E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354316
PNG
(1-(3-(tert-Butyl)-1-(3-((1-oxidophospholan-1-yl)me...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)c3)c3ccccc23)n(n1)-c1cccc(CP2(=O)CCCC2)c1
Show InChI InChI=1S/C40H41N6O3P/c1-40(2,3)36-26-38(46(45-36)30-15-11-12-28(24-30)27-50(48)22-9-10-23-50)44-39(47)43-34-18-19-35(33-17-8-7-16-32(33)34)49-31-20-21-41-37(25-31)42-29-13-5-4-6-14-29/h4-8,11-21,24-26H,9-10,22-23,27H2,1-3H3,(H,41,42)(H2,43,44,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.04E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354298
PNG
((S)-1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phe...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(n3)N3CCC[C@H]3CO)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C35H40N7O4P/c1-35(2,3)30-21-31(42(40-30)23-12-14-25(15-13-23)47(4,5)45)38-34(44)37-28-16-17-29(27-11-7-6-10-26(27)28)46-32-18-19-36-33(39-32)41-20-8-9-24(41)22-43/h6-7,10-19,21,24,43H,8-9,20,22H2,1-5H3,(H2,37,38,44)/t24-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.13E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354312
PNG
(1-(1-(3-((dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1ccccc1Nc1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3cccc(CP(C)(C)=O)c3)C(C)C)c3ccccc23)n1
Show InChI InChI=1S/C37H38N7O4P/c1-24(2)31-22-34(44(43-31)26-12-10-11-25(21-26)23-49(4,5)46)41-37(45)40-29-17-18-32(28-14-7-6-13-27(28)29)48-35-19-20-38-36(42-35)39-30-15-8-9-16-33(30)47-3/h6-22,24H,23H2,1-5H3,(H,38,39,42)(H2,40,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.92E+3n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354301
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Sc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35N6O3PS/c1-36(2,3)31-23-32(42(41-31)24-15-17-25(18-16-24)46(4,5)44)39-34(43)38-29-19-20-30(28-14-10-9-13-27(28)29)45-33-21-22-37-35(40-33)47-26-11-7-6-8-12-26/h6-23H,1-5H3,(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354287
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(c1ccccc1)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-24-33(44(42-32)26-16-18-27(19-17-26)48(5,6)46)40-36(45)39-30-20-21-31(29-15-11-10-14-28(29)30)47-34-22-23-38-35(41-34)43(4)25-12-8-7-9-13-25/h7-24H,1-6H3,(H2,39,40,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354300
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc(cc4)S(F)(F)(F)(F)F)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35F5N7O3PS/c1-36(2,3)31-22-32(48(47-31)24-12-14-25(15-13-24)52(4,5)50)45-35(49)44-29-18-19-30(28-9-7-6-8-27(28)29)51-33-20-21-42-34(46-33)43-23-10-16-26(17-11-23)53(37,38,39,40)41/h6-22H,1-5H3,(H,42,43,46)(H2,44,45,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354301
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Sc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35N6O3PS/c1-36(2,3)31-23-32(42(41-31)24-15-17-25(18-16-24)46(4,5)44)39-34(43)38-29-19-20-30(28-14-10-9-13-27(28)29)45-33-21-22-37-35(40-33)47-26-11-7-6-8-12-26/h6-23H,1-5H3,(H2,38,39,43)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354301
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Sc4ccccc4)n3)c3ccccc23)n(n1)-c1ccc(cc1)P(C)(C)=O
Show InChI InChI=1S/C36H35N6O3PS/c1-36(2,3)31-23-32(42(41-31)24-15-17-25(18-16-24)46(4,5)44)39-34(43)38-29-19-20-30(28-14-10-9-13-27(28)29)45-33-21-22-37-35(40-33)47-26-11-7-6-8-12-26/h6-23H,1-5H3,(H2,38,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354321
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(c4)C(F)(F)F)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O5P/c1-28(2)37-26-39(54(52-37)32-9-7-8-29(22-32)27-60(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-31-23-30(43(44,45)46)24-33(25-31)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354302
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(CCCO)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C34H40N7O4P/c1-34(2,3)29-22-30(41(39-29)23-12-14-24(15-13-23)46(5,6)44)37-33(43)36-27-16-17-28(26-11-8-7-10-25(26)27)45-31-18-19-35-32(38-31)40(4)20-9-21-42/h7-8,10-19,22,42H,9,20-21H2,1-6H3,(H2,36,37,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354326
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)C)c4ncccc34)n2)cc(OCCN2CCOCC2)c1
Show InChI InChI=1S/C42H48N9O6P/c1-28(2)36-26-38(51(49-36)31-9-6-8-29(22-31)27-58(4,5)53)47-42(52)46-35-11-12-37(34-10-7-14-43-40(34)35)57-39-13-15-44-41(48-39)45-30-23-32(54-3)25-33(24-30)56-21-18-50-16-19-55-20-17-50/h6-15,22-26,28H,16-21,27H2,1-5H3,(H,44,45,48)(H2,46,47,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM354287
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(c1ccccc1)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C37H38N7O3P/c1-37(2,3)32-24-33(44(42-32)26-16-18-27(19-17-26)48(5,6)46)40-36(45)39-30-20-21-31(29-15-11-10-14-28(29)30)47-34-22-23-38-35(41-34)43(4)25-12-8-7-9-13-25/h7-24H,1-6H3,(H2,39,40,45)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Glycogen synthase kinase-3


(Homo sapiens (Human))
BDBM354320
PNG
(1-(1-(3-((Dimethylphosphoryl)methyl)phenyl)-3-isop...)
Show SMILES CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OCCN5CCOCC5)cc(OC(F)(F)F)c4)n3)c3ccccc23)n(n1)-c1cccc(CP(C)(C)=O)c1
Show InChI InChI=1S/C43H46F3N8O6P/c1-28(2)37-26-39(54(52-37)31-9-7-8-29(22-31)27-61(3,4)56)50-42(55)49-36-12-13-38(35-11-6-5-10-34(35)36)59-40-14-15-47-41(51-40)48-30-23-32(25-33(24-30)60-43(44,45)46)58-21-18-53-16-19-57-20-17-53/h5-15,22-26,28H,16-21,27H2,1-4H3,(H,47,48,51)(H2,49,50,55)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against the GSK 3?? enzyme isoform (Invitrogen), are evaluated by determining the level of ac...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM354302
PNG
(1-(3-(tert-Butyl)-1-(4-(dimethylphosphoryl)phenyl)...)
Show SMILES CN(CCCO)c1nccc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc(cc3)P(C)(C)=O)C(C)(C)C)c3ccccc23)n1
Show InChI InChI=1S/C34H40N7O4P/c1-34(2,3)29-22-30(41(39-29)23-12-14-24(15-13-23)46(5,6)44)37-33(43)36-27-16-17-28(26-11-8-7-10-25(26)27)45-31-18-19-35-32(38-31)40(4)20-9-21-42/h7-8,10-19,22,42H,9,20-21H2,1-6H3,(H2,36,37,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9796742 (2017)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%